Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
Helping Women Thrive in Cybersecurity Careers
Karen Worstell, Senior Cybersecurity Strategist at VMware, joins ChedHER to discuss the biggest trends and threats in cybersecurity going into 2022, and advice for women in the cybersecurity and tech industries.
Possible Omicron Superspreader, Shutdown Averted & Love, Hate, Ate
It's Friday at long last. Jill and Carlo cover the latest on Omicron, including a possible superspreader event in NYC. Plus, previewing the November jobs report, a new Zoom feature no one asked for, and when it's no longer a good idea to eat Thanksgiving leftovers.
Square Changes Corporate Name to Block
Square is changing its name to Block. It comes as the company expands beyond its original credit card reader business and into blockchain and crypto technology. The name change will go into effect on December 10th, and the company says the name change, "creates room for further growth." Jim Anderson, CEO, SocialFlow joined Cheddar Movers to discuss.
Global Markets Impacted By Omicron Fears
Stock markets around the world continue to be impacted by fears of the new Omicron COVID-19 variant. President Biden today reiterated his stance that the new strain is cause for concern, but not cause for panic. Wells Fargo Investment Institute Global Equity Strategist Scott Wren joined Cheddar News' Closing Bell to discuss.
Load More